Clinical Trials For frontotemporal dementia To Start By 2013

.

Clinical Trials For frontotemporal dementia To Start By 2013

A neurodegenerative disease, frontotemporal dementia starts with silence and damages personality traits and then affects the brain. It gets very late for doctors to address the problem and till the time they get to know about, a person suffering from it, is left with very less time.

The disease was first discovered some 100 years back, but then also researchers have not been able to find probable reasons as well as treatment of the problem. It has also been found those maximum survival years of person after diagnosis of disease is not more than eight years.

However, researchers at the University of California have identified drugs that can treat the rare neurodegenerative problem. It is said that the study researchers are going to initiate clinical trials for the same by 2013.

Dr. Bruce L. Miller, who is a Professor of neurology and psychiatry in University of California, said that it is high time that researchers should know that there are different subtypes of dementia. "I think at least some subtypes of frontotemporal dementia will be the first neurodegenerative diseases we find a cure for", said Miller.

Miller further said that there are chances that the development helps understanding Alzheimer's disease in a better way.


Latest News

Depending on Regulatory Approvals, Ferrari CEO Expects to Conclude IPO, Spin- of
Facebook’s Revenues Surpass Expectations
Fed Has Bright View of a Strengthening U.S Economy But Will be ‘Patient’ with In
Don Thompson  to Retire From the Post of  McDonald’s chief executive
Consumers Confidence Grows but Businesses are Worried
CEO says The Present Year is one of Transition for AT&T Inc.
The Federal Reserve Meets for two Days: Likely to Stick to Initial Plans of Incr
New Areas to be Opened Off the East Coast for Oil Exploration
Even with Low Inflation the Feds are Expected to Raise Interest Rates
Mattel Missed Analyst’s Expectation, Fires CEO
Reports of Mass Layoffs Flatly Denied by IBM
Good News for the Diabetic: FDA Approved Mobile Medical Application for Sharing